News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|July 26, 2022

Fezolinetant making waves for VMS

Author(s)Morgan Ebert, Managing Editor

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA grants IDE approval for FemBloc non-surgical permanent birth control | Image Credit: © Luciano Luppa - © Luciano Luppa - stock.adobe.com.

FDA grants IDE approval for FemBloc non-surgical permanent birth control

ByCeleste Krewson, Assistant Editor

November 4th 2025

FDA approves fosfomycin for treating cUTIs | Image Credit: © Anny Art - © Anny Art - stock.adobe.com.

FDA approves fosfomycin for treating cUTIs

ByCeleste Krewson, Assistant Editor

November 4th 2025

Step count tied to lower mortality and heart disease risk in older women | Image Credit: © Kay Abrahams/peopleimages.com - © Kay Abrahams/peopleimages.com - stock.adobe.com.

Step count tied to lower mortality and heart disease risk in older women

ByCeleste Krewson, Assistant Editor

November 3rd 2025

Contemporary OB/GYN week in review: TMS 2025 recap, menopause guidelines, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: TMS 2025 recap, menopause guidelines, and more

ByCeleste Krewson, Assistant Editor

October 31st 2025

Bruce Dorr, MD | Navigating menopause with BRCA: Testosterone’s potential in menopause care

Navigating menopause with BRCA: Testosterone’s potential in menopause care

ByBruce Dorr, MD, FACOG, URPS, IFMCP

October 31st 2025

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Kathleen N. Moore, MD, MS, FASCO; Susana Banerjee, MBBS, MA, FRCP, PhD; David M. O’Malley, MD; Ritu Salani, MD, MBA

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; David M. O’Malley, MD

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Kathleen N. Moore, MD, MS, FASCO; Prof Susana Banerjee, MBBS, MA, FRCP, PhD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Top 5 women's health headlines you missed in October 2025

Postpartum complications common in first year after birth

FDA approves fosfomycin for treating cUTIs

Elective egg freezing on the rise, but few patients return to use preserved oocytes

Researchers identify 4 distinct PCOS subtypes to guide treatment

© 2025 MJH Life Sciences^®

All rights reserved.